Diaceutics (LON:DXRX) Releases Quarterly Earnings Results

Diaceutics (LON:DXRX - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported GBX (2.02) (($0.03)) earnings per share for the quarter, Digital Look Earnings reports. Diaceutics had a negative net margin of 10.90% and a negative return on equity of 7.15%.

Diaceutics Stock Up 2.6%

DXRX stock traded up GBX 3.20 ($0.04) during trading on Tuesday, reaching GBX 128.20 ($1.69). The stock had a trading volume of 231,894 shares, compared to its average volume of 105,613. Diaceutics has a 1-year low of GBX 96 ($1.26) and a 1-year high of GBX 151 ($1.99). The company has a current ratio of 4.85, a quick ratio of 9.92 and a debt-to-equity ratio of 0.39. The company has a market capitalization of £108.19 million, a P/E ratio of -38.02 and a beta of 0.58. The firm has a fifty day moving average price of GBX 120.77 and a 200 day moving average price of GBX 126.92.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.